Melatonin regulation of phase separation in Neuro-PASC: out-maneuvering Janus-faced amyloids

Abstract

The SAR-CoV-2 virus has evolved to co-exist with human hosts, albeit at a substantial energetic cost resulting in post-infection neurological manifestations [Neuro-post-acute sequelae of SARS-CoV-2 infection (PASC)] that significantly impact public health and economic productivity on a global scale. One of the main molecular mechanisms responsible for the development of Neuro-PASC, in individuals of all ages, is the formation and inadequate proteolysis/clearance of phase-separated amyloid crystalline aggregates—a hallmark feature of aging-related neurodegenerative disorders. Amyloidogenesis during viral infection and persistence is a natural, inevitable, protective defense response that is exacerbated by SARS-CoV-2. Acting as chemical catalyst, SARS-CoV-2 accelerates hydrophobic collapse and the heterogeneous nucleation of amorphous amyloids into stable β-sheet aggregates. The clearance of amyloid aggregates is most effective during slow wave sleep, when high levels of adenosine triphosphate (ATP)—a biphasic modulator of biomolecular condensates—and melatonin are available to solubilize amyloid aggregates for removal. The dysregulation of mitochondrial dynamics by SARS-CoV-2, in particular fusion and fission homeostasis, impairs the proper formation of distinct mitochondrial subpopulations that can remedy challenges created by the diversion of substrates away from oxidative phosphorylation towards glycolysis to support viral replication and maintenance. The subsequent reduction of ATP and inhibition of melatonin synthesis during slow wave sleep results in incomplete brain clearance of amyloid aggregates, leading to the development of neurological manifestations commonly associated with age-related neurodegenerative disorders. Exogenous melatonin not only prevents mitochondrial dysfunction but also elevates ATP production, effectively augmenting the solubilizing effect of the adenosine moiety to ensure the timely, optimal disaggregation and clearance of pathogenic amyloid aggregates in the prevention and attenuation of Neuro-PASC.

Keywords

Adenosine moiety effect / adenosine triphosphate (ATP) / mitochondrial dynamics / glymphatic system / neurodegenerative disorders / protein hydration / slow wave sleep / viral persistence

References

[1] Moghimi N,Di Napoli M,Biller J,Siegler JE,Shekhar R,McCullough LD,et al.The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.Curr Neurol Neurosci Rep.2021;21:44.

[2] Krishnan K,Miller AK,Reiter K,Bonner-Jackson A.Neurocognitive Profiles in Patients With Persisting Cognitive Symptoms Associated With COVID-19.Arch Clin Neuropsychol.2022;37:729-37.

[3] Shanley JE,Valenciano AF,Timmons G,Miner AE,Kakarla V,Rempe T,et al.Longitudinal evaluation of neurologic-post acute sequelae SARS-CoV-2 infection symptoms.Ann Clin Transl Neurol.2022;9:995-1010.

[4] Cahan J,Finley JA,Cotton E,Orban ZS,Jimenez M,Weintraub S,et al.Cognitive functioning in patients with neuro-PASC: the role of fatigue, mood, and hospitalization status.Front Neurol.2024;15:1401796.

[5] Goldstein DS,Mina Y,Walitt B,Sullivan P,Enose-Akahata Y,Jacobson S,et al.Persistent Autonomic and Immunologic Abnormalities in Neurologic Post-Acute Sequelae of SARS-CoV2 Infection.Neurology.2024;103:e209742.

[6] Hampshire A,Azor A,Atchison C,Trender W,Hellyer PJ,Giunchiglia V,et al.Cognition and Memory after Covid-19 in a Large Community Sample.N Engl J Med.2024;390:806-18.

[7] Austin TA,Thomas ML,Lu M,Hodges CB,Darowski ES,Bergmans R,et al.Meta-analysis of Cognitive Function Following Non-severe SARS-CoV-2 Infection.Neuropsychol Rev.2024;[Epub ahead of print]

[8] Mina Y,Enose-Akahata Y,Hammoud DA,Videckis AJ,Narpala SR,O’Connell SE,et al.Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection.Neurol Neuroimmunol Neuroinflamm.2023;10:e200097.

[9] Nouraeinejad A.Brain fog as a Long-term Sequela of COVID-19.SN Compr Clin Med.2023;5:9.

[10] Iosifescu AL,Hoogenboom WS,Buczek AJ,Fleysher R,Duong TQ.New-onset and persistent neurological and psychiatric sequelae of COVID-19 compared to influenza: A retrospective cohort study in a large New York City healthcare network.Int J Methods Psychiatr Res.2022;31:e1914.

[11] Pinnock FS,Rich JB,Vasquez B,Wiegand M,Patcai J,Troyer AK,et al.Neurocognitive Outcome Following Recovery from Severe Acute Respiratory Syndrome – Coronavirus-1 (SARS-CoV-1).J Int Neuropsychol Soc.2022;28:891-901.

[12] Rong Z,Mai H,Ebert G,Kapoor S,Puelles VG,Czogalla J,et al.Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19.Cell Host Microbe.2024;32:2112-30.e10.

[13] Taquet M,Skorniewska Z,De Deyn T,Hampshire A,Trender WR,Hellyer PJ,et al.PHOSP-COVID Study Collaborative Group.Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.Lancet Psychiatry.2024;11:696-708.

[14] Hurtado C,Rojas-Gualdrón DF,Pérez Giraldo GS,Villegas Arbelaez E,Mantilla SEM,Campuzano-Sierra M,et al.Neurologic manifestations of Long COVID in Colombia: a comparative analysis of post-hospitalization vs. non-hospitalized patients.Front Hum Neurosci.2024;18:1450110.

[15] Choudhury NA,Mukherjee S,Singer T,Venkatesh A,Perez Giraldo GS,Jimenez M,et al.Neurologic Manifestations of Long COVID Disproportionately Affect Young and Middle-Age Adults.Ann Neurol.2025;97:369-83.

[16] Zorzo C,Solares L,Mendez M,Mendez-Lopez M.Hippocampal alterations after SARS-CoV-2 infection: A systematic review.Behav Brain Res.2023;455:114662.

[17] Kumar PR,Shilpa B,Jha RK.Brain disorders: Impact of mild SARS-CoV-2 may shrink several parts of the brain.Neurosci Biobehav Rev.2023;149:105150.

[18] Douaud G,Lee S,Alfaro-Almagro F,Arthofer C,Wang C,McCarthy P,et al.SARS-CoV-2 is associated with changes in brain structure in UK Biobank.Nature.2022;604:697-707.

[19] Bayat AH,Azimi H,Hassani Moghaddam M,Ebrahimi V,Fathi M,Vakili K,et al.COVID-19 causes neuronal degeneration and reduces neurogenesis in human hippocampus.Apoptosis.2022;27:852-68.

[20] Kishimoto-Urata M,Urata S,Kagoya R,Imamura F,Nagayama S,Reyna RA,et al.Prolonged and extended impacts of SARS-CoV-2 on the olfactory neurocircuit.Sci Rep.2022;12:5728.

[21] Soung AL,Vanderheiden A,Nordvig AS,Sissoko CA,Canoll P,Mariani MB,et al.COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis.Brain.2022;145:4193-201.

[22] Oh SJ,Kumari P,Auroni TT,Stone S,Pathak H,Elsharkawy A,et al.Upregulation of Neuroinflammation-Associated Genes in the Brain of SARS-CoV-2-Infected Mice.Pathogens.2024;13:528.

[23] Netto CA,Porcionatto MA.Chapter 31 - Neuroinflammation following SARS-CoV-2 infection. In: Rajendram R,Preedy VR,Patel VB,Martin CR. editors.Linking Neuroscience and Behavior in COVID-19Academic Press; 2024. pp. 361–71.

[24] Frank MG,Ball JB,Hopkins S,Kelley T,Kuzma AJ,Thompson RS,et al.SARS-CoV-2 S1 subunit produces a protracted priming of the neuroinflammatory, physiological, and behavioral responses to a remote immune challenge: A role for corticosteroids.Brain Behav Immun.2024;121:87-103.

[25] Kavanagh E.Long Covid brain fog: a neuroinflammation phenomenon?Oxf Open Immunol.2022;3:iqac007.

[26] van Blerk TB,Loos B.Chapter 7 - SARS-CoV-2 bulldozes the autophagy pathway and unhinges mitochondrial quality control thereby driving neurodegeneration—A hypothesis. In: Rajendram R,Preedy VR,Patel VB. editors.Features, Transmission, Detection, and Case Studies in COVID-19Academic Press; 2024. pp. 79–95.

[27] Shang C,Liu Z,Zhu Y,Lu J,Ge C,Zhang C,et al.SARS-CoV-2 Causes Mitochondrial Dysfunction and Mitophagy Impairment.Front Microbiol.2022;12:780768.

[28] Shteinfer-Kuzmine A,Verma A,Bornshten R,Ben Chetrit E,Ben-Ya’acov A,Pahima H,et al.Elevated serum mtDNA in COVID-19 patients is linked to SARS-CoV-2 envelope protein targeting mitochondrial VDAC1, inducing apoptosis and mtDNA release.Apoptosis.2024;29:2025-46.

[29] Pliss A,Kuzmin AN,Prasad PN,Mahajan SD.Mitochondrial Dysfunction: A Prelude to Neuropathogenesis of SARS-CoV-2.ACS Chem Neurosci.2022;13:308-12.

[30] Gavilán E,Medina-Guzman R,Bahatyrevich-Kharitonik B,Ruano D.Protein Quality Control Systems and ER Stress as Key Players in SARS-CoV-2-Induced Neurodegeneration.Cells.2024;13:123.

[31] Maliha ST,Fatemi R,Araf Y.COVID-19 and the brain: understanding the pathogenesis and consequences of neurological damage.Mol Biol Rep.2024;51:318.

[32] Bonhenry D,Charnley M,Gonçalves J,Hammarström P,Heneka MT,Itzhaki R,et al.SARS-CoV-2 infection as a cause of neurodegeneration.Lancet Neurol.2024;23:562-3.

[33] Al-Aly Z,Rosen CJ.Long Covid and Impaired Cognition — More Evidence and More Work to Do.N Engl J Med.2024;390:858-60.

[34] Bedran D,Bedran G,Kote S.A Comprehensive Review of Neurodegenerative Manifestations of SARS-CoV-2.Vaccines (Basel).2024;12:222.

[35] Zhao J,Xia F,Jiao X,Lyu X.Long COVID and its association with neurodegenerative diseases: pathogenesis, neuroimaging, and treatment.Front Neurol.2024;15:1367974.

[36] Mohammadi-Nejad AR,Craig M,Cox E,Chen X,Jenkins RG,Francis S,et al.Brains Under Stress: Unravelling the Effects of the COVID-19 Pandemic on Brain AgeingmedRxiv 2024.07.22.24310790 [Preprint]. 2024 [cited 2024 Dec 4]. Available from: https://doi.org/10.1101/2024.07.22.24310790

[37] Milton NGN.SARS-CoV-2 amyloid, is COVID-19-exacerbated dementia an amyloid disorder in the making?Front Dement.2023;2:1233340.

[38] Rahmati M,Yon DK,Lee SW,Soysal P,Koyanagi A,Jacob L,et al.New-onset neurodegenerative diseases as long-term sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis.J Med Virol.2023;95:e28909.

[39] Deng L,Ding L,Duan X,Peng Y.Shared molecular signatures between coronavirus infection and neurodegenerative diseases provide targets for broad-spectrum drug development.Sci Rep.2023;13:5457.

[40] Strong MJ.SARS-CoV-2, aging, and Post-COVID-19 neurodegeneration.J Neurochem.2023;165:115-30.

[41] Yasir S,Jin Y,Razzaq FA,Caballero-Moreno A,Galán-García L,Ren P,et al.The determinants of COVID-induced brain dysfunctions after SARS-CoV-2 infection in hospitalized patients.Front Neurosci.2024;17:1249282.

[42] Li C,Liu J,Lin J,Shang H.COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization study.Transl Psychiatry.2022;12:283.

[43] Denaro CA,Haloush YI,Hsiao SY,Orgera JJ,Osorio T,Riggs LM,et al.COVID-19 and neurodegeneration: The mitochondrial connection.Aging Cell.2022;21:e13727.

[44] Jiang Y,Neal J,Sompol P,Yener G,Arakaki X,Norris CM,et al.Parallel electrophysiological abnormalities due to COVID-19 infection and to Alzheimer’s disease and related dementia.Alzheimers Dement.2024;20:7296-319.

[45] Shrestha A,Chen R,Kunasekaran M,Honeyman D,Notaras A,Sutton B,et al.The risk of cognitive decline and dementia in older adults diagnosed with COVID-19: A systematic review and meta-analysis.Ageing Res Rev.2024;101:102448.

[46] Gondelaud F,Lozach PY,Longhi S.Viral amyloids: New opportunities for antiviral therapeutic strategies.Curr Opin Struct Biol.2023;83:102706.

[47] Levine KS,Leonard HL,Blauwendraat C,Iwaki H,Johnson N,Bandres-Ciga S,et al.Virus exposure and neurodegenerative disease risk across national biobanks.Neuron.2023;111:1086-93.e2.

[48] Chiricosta L,Gugliandolo A,Mazzon E.SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer’s Disease Patients.Int J Mol Sci.2021;22:13603.

[49] Bettio LEB,Rajendran L,Gil-Mohapel J.The effects of aging in the hippocampus and cognitive decline.Neurosci Biobehav Rev.2017;79:66-86.

[50] Shan D,Wang C,Crawford T,Holland C.Temporal association between COVID-19 infection and subsequent new-onset dementia in older adults (aged 60 years and above): a systematic review and meta-analysis.Lancet.2024;404:S73.

[51] Invernizzi A,Renzetti S,van Thriel C,Rechtman E,Patrono A,Ambrosi C,et al.COVID-19 related cognitive, structural and functional brain changes among Italian adolescents and young adults: a multimodal longitudinal case-control study.Transl Psychiatry.2024;14:402.

[52] Rua C,Raman B,Rodgers CT,Newcombe VFJ,Manktelow A,Chatfield DA,et al.Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations.Brain.2024;147:4121-30.

[53] Trender W,Hellyer PJ,Killingley B,Kalinova M,Mann AJ,Catchpole AP,et al.Changes in memory and cognition during the SARS-CoV-2 human challenge study.EClinicalMedicine.2024;76:102842.

[54] Benavides FFW,Kroeze EJBV,Leijten L,Schmitz KS,van Run P,Kuiken T,et al.Neuroinvasive and neurovirulent potential of SARS-CoV-2 in the acute and post-acute phase of intranasally inoculated ferretsbioRxiv 2024.09.21.614276 [Preprint]. 2024 [cited 2024 Dec 4]. Available from: https://doi.org/10.1101/2024.09.21.614276

[55] Safadieh GH,El Majzoub R,Abou Abbas L.Neuroimaging findings in children with COVID-19 infection: a systematic review and meta-analysis.Sci Rep.2024;14:4790.

[56] Genario R,Giacomini ACVV,Demin KA,Dos Santos BE,Marchiori NI,Volgin AD,et al.The evolutionarily conserved role of melatonin in CNS disorders and behavioral regulation: Translational lessons from zebrafish.Neurosci Biobehav Rev.2019;99:117-27.

[57] Lerner AB,Case JD,Takahashi Y,Lee TH,Mori W.ISOLATION OF MELATONIN, THE PINEAL GLAND FACTOR THAT LIGHTENS MELANOCYTES¹.J Am Chem Soc.1958;80:2587.

[58] Reiter RJ,Sharma R,Tan DX,Chuffa LGA,da Silva DGH,Slominski AT,et al.Dual sources of melatonin and evidence for different primary functions.Front Endocrinol (Lausanne).2024;15:1414463.

[59] Xie X,Ding D,Bai D,Zhu Y,Sun W,Sun Y,et al.Melatonin biosynthesis pathways in nature and its production in engineered microorganisms.Synth Syst Biotechnol.2022;7:544-53.

[60] Lee K,Choi GH,Back K.Functional Characterization of Serotonin N-Acetyltransferase in Archaeon Thermoplasma volcanium.Antioxidants (Basel).2022;11:596.

[61] Loh D,Reiter RJ.Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders.Antioxidants (Basel).2021;10:1483.

[62] Loh D,Reiter RJ.Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance.Molecules.2022;27:705.

[63] Loh D,Reiter RJ.Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19.Int J Mol Sci.2022;23:8122.

[64] Loh D,Reiter RJ.Light, Water, and Melatonin: The Synergistic Regulation of Phase Separation in Dementia.Int J Mol Sci.2023;24:5835.

[65] Loh D,Reiter RJ.Melatonin, ATP, and Cataracts: The Two Faces of Crystallin Phase SeparationQeios [Preprint]. 2024 [cited 2024 Dec 4]. Available from: https://doi.org/10.32388/D09YND

[66] Loh D,Reiter RJ.The mitochondria chronicles of melatonin and ATP: Guardians of phase separation.Mitochondrial Commun.2024;2:67-84.

[67] Hardy J,Allsop D.Amyloid deposition as the central event in the aetiology of Alzheimer’s disease.Trends Pharmacol Sci.1991;12:383-8.

[68] Pike CJ,Burdick D,Walencewicz AJ,Glabe CG,Cotman CW.Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state.J Neurosci.1993;13:1676-87.

[69] Lorenzo A,Yankner BA.Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.Proc Natl Acad Sci U S A.1994;91:12243-7.

[70] Mucke L,Masliah E,Yu GQ,Mallory M,Rockenstein EM,Tatsuno G,et al.High-level neuronal expression of Aβ_1–42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.J Neurosci.2000;20:4050-8.

[71] Dahlgren KN,Manelli AM,Stine WB Jr,Baker LK,Krafft GA,LaDu MJ.Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability.J Biol Chem.2002;277:32046-53.

[72] Jack CR Jr,Wiste HJ,Weigand SD,Rocca WA,Knopman DS,Mielke MM,et al.Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study.Lancet Neurol.2014;13:997-1005.

[73] Morris GP,Clark IA,Vissel B.Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer’s disease.Acta Neuropathol Commun.2014;2:135.

[74] Donohue MC,Sperling RA,Petersen R,Sun CK,Weiner MW,Aisen PSAlzheimer’s Disease Neuroimaging Initiative.Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons.JAMA.2017;317:2305-16.

[75] Hedden T,Oh H,Younger AP,Patel TA.Meta-analysis of amyloid-cognition relations in cognitively normal older adults.Neurology.2013;80:1341-8.

[76] Chételat G,La Joie R,Villain N,Perrotin A,de La Sayette V,Eustache F,et al.Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer’s disease.Neuroimage Clin.2013;2:356-65.

[77] Villemagne VL,Burnham S,Bourgeat P,Brown B,Ellis KA,Salvado O,et al.Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group.Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study.Lancet Neurol.2013;12:357-67.

[78] Whitson HE,Banks WA,Diaz MM,Frost B,Kellis M,Lathe R,et al.New approaches for understanding the potential role of microbes in Alzheimer’s disease.Brain Behav Immun Health.2024;36:100743.

[79] Barnhart MM,Chapman MR.Curli biogenesis and function.Annu Rev Microbiol.2006;60:131-47.

[80] Prosswimmer T,Heng A,Daggett V.Mechanistic insights into the role of amyloid-β in innate immunity.Sci Rep.2024;14:5376.

[81] Baltutis V,O’Leary PD,Martin LL.Self-Assembly of Linear, Natural Antimicrobial Peptides: An Evolutionary Perspective.Chempluschem.2022;87:e202200240.

[82] Eroglu M,Zocher T,McAuley J,Webster R,Xiao MZX,Yu B,et al.Noncanonical inheritance of phenotypic information by protein amyloids.Nat Cell Biol.2024;26:1712-24.

[83] Wang H,Zhang J,Toso D,Liao S,Sedighian F,Gunsalus R,et al.Hierarchical organization and assembly of the archaeal cell sheath from an amyloid-like protein.Nat Commun.2023;14:6720.

[84] Zajkowski T,Lee MD,Mondal SS,Carbajal A,Dec R,Brennock PD,et al.The Hunt for Ancient Prions: Archaeal Prion-Like Domains Form Amyloid-Based Epigenetic Elements.Mol Biol Evol.2021;38:2088-103.

[85] Kwiatkowski W,Greenwald J,Murzakhmetov L,Robinson RC,Riek R.Short Peptide Amyloids Are a Potential Sequence Pool for the Emergence of Proteins.J Mol Biol.2024;436:168495.

[86] Forterre P.The origin of viruses and their possible roles in major evolutionary transitions.Virus Res.2006;117:5-16.

[87] Moreira D,López-García P.Evolution of viruses and cells: do we need a fourth domain of life to explain the origin of eukaryotes?Philos Trans R Soc Lond B Biol Sci.2015;370:20140327.

[88] Caetano-Anollés G.Chapter 1 - Phylogenomic analysis and the origin and early evolution of viruses. In: Mokrousov I,Shitikov E. editors.PhylogenomicsAcademic Press; 2024. pp. 3–34.

[89] Patel MR,Emerman M,Malik HS.Paleovirology—ghosts and gifts of viruses past.Curr Opin Virol.2011;1:304-9.

[90] Prangishvili D,Forterre P,Garrett RA.Viruses of the Archaea: a unifying view.Nat Rev Microbiol.2006;4:837-48.

[91] Sensevdi ER,Sourrouille ZA,Quax TE.Host range and cell recognition of archaeal viruses.Curr Opin Microbiol.2024;77:102423.

[92] Krupovic M,Cvirkaite-Krupovic V,Iranzo J,Prangishvili D,Koonin EV.Viruses of archaea: Structural, functional, environmental and evolutionary genomics.Virus Res.2018;244:181-93.

[93] Nan H,Chen H,Tuite MF,Xu X.A viral expression factor behaves as a prion.Nat Commun.2019;10:359.

[94] Kuiper BP,Schöntag AMC,Oksanen HM,Daum B,Quax TEF.Archaeal virus entry and egress.Microlife.2024;5:uqad048.

[95] Baquero DP,Liu Y,Wang F,Egelman EH,Prangishvili D,Krupovic M.Chapter Four - Structure and assembly of archaeal viruses. In: Kielian M,Mettenleiter TC,Roossinck MJ. editors.Advances in Virus ResearchAcademic Press; 2020. pp. 127–64.

[96] Espay AJ,Okun MS.Abandoning the Proteinopathy Paradigm in Parkinson Disease.JAMA Neurol.2023;80:123-4.

[97] Ezzat K,Pernemalm M,Pålsson S,Roberts TC,Järver P,Dondalska A,et al.The viral protein corona directs viral pathogenesis and amyloid aggregation.Nat Commun.2019;10:2331.

[98] Ezzat K,Sturchio A,Espay AJ.Proteins Do Not Replicate, They Precipitate: Phase Transition and Loss of Function Toxicity in Amyloid Pathologies.Biology (Basel).2022;11:535.

[99] Nutini A.Amyloid oligomers and their membrane toxicity - A perspective study.Prog Biophys Mol Biol.2024;187:9-20.

[100] Matthes D,de Groot BL.Molecular dynamics simulations reveal the importance of amyloid-beta oligomer β-sheet edge conformations in membrane permeabilization.J Biol Chem.2023;299:103034.

[101] Korshavn KJ,Satriano C,Lin Y,Zhang R,Dulchavsky M,Bhunia A,et al.Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β.J Biol Chem.2017;292:4638-50.

[102] Demuro A,Parker I.Cytotoxicity of intracellular Aβ₄₂ amyloid oligomers involves Ca²⁺ release from the endoplasmic reticulum by stimulated production of inositol trisphosphate.J Neurosci.2013;33:3824-33.

[103] Jülicher F,Weber CA.Droplet Physics and Intracellular Phase Separation.Annu Rev Condens Matter Phys.2024;15:237-61.

[104] Riback JA,Zhu L,Ferrolino MC,Tolbert M,Mitrea DM,Sanders DW,et al.Composition-dependent thermodynamics of intracellular phase separation.Nature.2020;581:209-14.

[105] Falahati H,Haji-Akbari A.Thermodynamically driven assemblies and liquid-liquid phase separations in biology.Soft Matter.2019;15:1135-54.

[106] Banani SF,Lee HO,Hyman AA,Rosen MK.Biomolecular condensates: organizers of cellular biochemistry.Nat Rev Mol Cell Biol.2017;18:285-98.

[107] Mukherjee S,Poudyal M,Dave K,Kadu P,Maji SK.Protein misfolding and amyloid nucleation through liquid-liquid phase separation.Chem Soc Rev.2024;53:4976-5013.

[108] Linsenmeier M,Faltova L,Morelli C,Capasso Palmiero U,Seiffert C,Küffner AM,et al.The interface of condensates of the hnRNPA1 low-complexity domain promotes formation of amyloid fibrils.Nat Chem.2023;15:1340-9.

[109] Andreghetti D,Dall’Asta L,Gamba A,Kolokolov I,Lebedev V.Molecular sorting on a fluctuating membranearXiv:2410.21186 [Preprint]. 2024 [cited 2024 Dec 4]: [9 p.]. Available from: https://doi.org/10.48550/arXiv.2410.21186

[110] Stuwe H,Reardon PN,Yu Z,Shah S,Hughes K,Barbar EJ.Phosphorylation in the Ser/Arg-rich region of the nucleocapsid of SARS-CoV-2 regulates phase separation by inhibiting self-association of a distant helix.J Biol Chem.2024;300:107354.

[111] Laughlin PM,Young K,Gonzalez-Gutierrez G,Wang JC,Zlotnick A.A narrow ratio of nucleic acid to SARS-CoV-2 N-protein enables phase separation.J Biol Chem.2024;300:107831.

[112] Li M,Hou Y,Zhou Y,Yang Z,Zhao H,Jian T,et al.LLPS of FXR proteins drives replication organelle clustering for β-coronaviral proliferation.J Cell Biol.2024;223:e202309140.

[113] Strong MJ,McLellan C,Kaplanis B,Droppelmann CA,Junop M.Phase Separation of SARS-CoV-2 Nucleocapsid Protein with TDP-43 Is Dependent on C-Terminus Domains.Int J Mol Sci.2024;25:8779.

[114] Dong H,Zhang H,Jalin J,He Z,Wang R,Huang L,et al.Nucleocapsid proteins from human coronaviruses possess phase separation capabilities and promote FUS pathological aggregation.Protein Sci.2023;32:e4826.

[115] Kobayashi R,Nabika H.Liquid-liquid phase separation induced by crowding condition affects amyloid-β aggregation mechanism.Soft Matter.2024;20:5331-42.

[116] Visser BS,Lipiński WP,Spruijt E.The role of biomolecular condensates in protein aggregation.Nat Rev Chem.2024;8:686-700.

[117] Karger S,Miali ME,Solomonov A,Eliaz D,Varsano N,Shimanovich U.Protein Compartments Modulate Fibrillar Self-Assembly.Small.2024;20:2308069.

[118] Ziaunys M,Sulskis D,Veiveris D,Kopustas A,Snieckute R,Mikalauskaite K,et al.Liquid–liquid phase separation of alpha-synuclein increases the structural variability of fibrils formed during amyloid aggregation.FEBS J.2024;291:4522-38.

[119] Yuan C,Xing R,Cui J,Fan W,Li J,Yan X.Multistep Desolvation as a Fundamental Principle Governing Peptide Self-Assembly Through Liquid–Liquid Phase Separation.CCS Chem.2024;6:255-65.

[120] Chang R,Yuan C,Zhou P,Xing R,Yan X.Peptide Self-assembly: From Ordered to Disordered.Acc Chem Res.2024;57:289-301.

[121] Avni A,Swasthi HM,Majumdar A,Mukhopadhyay S.Intrinsically disordered proteins in the formation of functional amyloids from bacteria to humans.Prog Mol Biol Transl Sci.2019;166:109-43.

[122] Scollo F,La Rosa C.Amyloidogenic Intrinsically Disordered Proteins: New Insights into Their Self-Assembly and Their Interaction with Membranes.Life (Basel).2020;10:144.

[123] Uversky VN.On the Roles of Protein Intrinsic Disorder in the Origin of Life and Evolution.Life (Basel).2024;14:1307.

[124] Knowles TP,Fitzpatrick AW,Meehan S,Mott HR,Vendruscolo M,Dobson CM,et al.Role of intermolecular forces in defining material properties of protein nanofibrils.Science.2007;318:1900-3.

[125] Michaels TCT,Qian D,Šarić A,Vendruscolo M,Linse S,Knowles TPJ.Amyloid formation as a protein phase transition.Nat Rev Phys.2023;5:379-97.

[126] Mukherjee S,Sakunthala A,Gadhe L,Poudyal M,Sawner AS,Kadu P,et al.Liquid-liquid Phase Separation of α-Synuclein: A New Mechanistic Insight for α-Synuclein Aggregation Associated with Parkinson’s Disease Pathogenesis.J Mol Biol.2023;435:167713.

[127] Šneiderienė G,Díaz AG,Adhikari SD,Wei J,Michaels T,Šneideris T,et al.The Alzheimer’s Aβ peptide forms biomolecular condensates that trigger amyloid aggregationbioRxiv 2024.01.14.575549 [Preprint]. 2024 [cited 2024 Dec 4]. Available from: https://doi.org/10.1101/2024.01.14.575549

[128] Wegmann S,Eftekharzadeh B,Tepper K,Zoltowska KM,Bennett RE,Dujardin S,et al.Tau protein liquid-liquid phase separation can initiate tau aggregation.EMBO J.2018;37:e98049.

[129] Nilsson BL,Celebi Torabfam G,Dias CL.Peptide Self-Assembly into Amyloid Fibrils: Unbiased All-Atom Simulations.J Phys Chem B.2024;128:3320-8.

[130] Dobson CM,Knowles TPJ,Vendruscolo M.The Amyloid Phenomenon and Its Significance in Biology and Medicine.Cold Spring Harb Perspect Biol.2020;12:a033878.

[131] Ke PC,Sani MA,Ding F,Kakinen A,Javed I,Separovic F,et al.Implications of peptide assemblies in amyloid diseases.Chem Soc Rev.2017;46:6492-531.

[132] Buchanan JA,Varghese NR,Johnston CL,Sunde M.Functional Amyloids: Where Supramolecular Amyloid Assembly Controls Biological Activity or Generates New Functionality.J Mol Biol.2023;435:167919.

[133] Myers C,Cornwall GA.Host defense amyloids: Biosensors of the immune system?Andrology.2024;12:973-80.

[134] Stollar EJ,Smith DP.Uncovering protein structure.Essays Biochem.2020;64:649-80.

[135] Adamcik J,Mezzenga R.Amyloid Polymorphism in the Protein Folding and Aggregation Energy Landscape.Angew Chem Int Ed Engl.2018;57:8370-82.

[136] Cao S,Song Z,Rong J,Andrikopoulos N,Liang X,Wang Y,et al.Spike Protein Fragments Promote Alzheimer’s Amyloidogenesis.ACS Appl Mater Interfaces.2023;15:40317-29.

[137] Larsson J,Hellstrand E,Hammarström P,Nyström S.SARS-CoV-2 Spike amyloid fibrils specifically and selectively accelerates amyloid fibril formation of human prion protein and the amyloid β peptidebioRxiv 2023.09.01.555834 [Preprint]. 2023 [cited 2024 Dec 4]. Available from: https://doi.org/10.1101/2023.09.01.555834

[138] Nyström S,Hammarström P.Amyloidogenesis of SARS-CoV-2 Spike Protein.J Am Chem Soc.2022;144:8945-50.

[139] Coppola F,Pavlíček T,Král P.Coupling of SARS-CoV-2 to Aβ Amyloid Fibrils.ACS Omega.2024;9:9295-9.

[140] Zargan S,Jalili H,Dabirmanesh B,Mesdaghinia S,Khajeh K.Amyloidogenesis of SARS-CoV-2 delta plus and omicron variants receptor-binding domain (RBD): impact of SUMO fusion tag.Biotechnol Lett.2024;46:1037-48.

[141] Chang MH,Park JH,Lee HK,Choi JY,Koh YH.SARS-CoV-2 Spike Protein 1 Causes Aggregation of α-Synuclein via Microglia-Induced Inflammation and Production of Mitochondrial ROS: Potential Therapeutic Applications of Metformin.Biomedicines.2024;12:1223.

[142] Morozova OV,Manuvera VA,Barinov NA,Subcheva EN,Laktyushkin VS,Ivanov DA,et al.Self-assembling amyloid-like nanostructures from SARS-CoV-2 S1, S2, RBD and N recombinant proteins.Arch Biochem Biophys.2024;752:109843.

[143] Wu Z,Zhang X,Huang Z,Ma K.SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro.Int J Mol Sci.2022;23:3394.

[144] Tayeb-Fligelman E,Bowler JT,Tai CE,Sawaya MR,Jiang YX,Garcia G Jr,et al.Low complexity domains of the nucleocapsid protein of SARS-CoV-2 form amyloid fibrils.Nat Commun.2023;14:2379.

[145] Semerdzhiev SA,Fakhree MAA,Segers-Nolten I,Blum C,Claessens MMAE.Interactions between SARS-CoV-2 N-Protein and α-Synuclein Accelerate Amyloid Formation.ACS Chem Neurosci.2022;13:143-50.

[146] Nady A,Reichheld SE,Sharpe S.An amyloidogenic fragment of the SARS CoV-2 envelope protein promotes serum amyloid A misfolding and fibrillizationbioRxiv 2024.04.25.591137 [Preprint]. 2024 [cited 2024 Dec 4]. Available from: https://doi.org/10.1101/2024.04.25.591137

[147] Jana AK,Greenwood AB,Hansmann UHE.Presence of a SARS-CoV-2 Protein Enhances Amyloid Formation of Serum Amyloid A.J Phys Chem B.2021;125:9155-67.

[148] Nishide G,Lim K,Tamura M,Kobayashi A,Zhao Q,Hazawa M,et al.Nanoscopic Elucidation of Spontaneous Self-Assembly of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Open Reading Frame 6 (ORF6) Protein.J Phys Chem Lett.2023;14:8385-96.

[149] Charnley M,Islam S,Bindra GK,Engwirda J,Ratcliffe J,Zhou J,et al.Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19.Nat Commun.2022;13:3387.

[150] Bhardwaj T,Gadhave K,Kapuganti SK,Kumar P,Brotzakis ZF,Saumya KU,et al.Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes.Nat Commun.2023;14:945.

[151] Singh A,Chimata AV,Deshpande P,Bajpai S,Sangeeth A,Rajput M,et al.SARS-CoV2 Nsp3 protein triggers cell death and exacerbates amyloid β42-mediated neurodegeneration.Neural Regen Res.2024;19:1385-92.

[152] Christ W,Kapell S,Sobkowiak MJ,Mermelekas G,Evertsson B,Sork H,et al.SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF Resulting in Drastic Soluble Protein Depletion.ACS Chem Neurosci.2024;15:4095-104.

[153] Imai M,Kawakami F,Uematsu T,Matsumoto T,Kawashima R,Kurosaki Y,et al.SARS-CoV-2 propagation to the TPH2-positive neurons in the ventral tegmental area induces cell death via GSK3β-dependent accumulation of phosphorylated tau.PLoS One.2024;19:e0312834.

[154] Rebeaud ME,Mallik S,Goloubinoff P,Tawfik DS.On the evolution of chaperones and cochaperones and the expansion of proteomes across the Tree of Life.Proc Natl Acad Sci U S A.2021;118:e2020885118.

[155] Schroeder HT,De Lemos Muller CH,Heck TG,Krause M,Homem de Bittencourt PI Jr.The dance of proteostasis and metabolism: Unveiling the caloristatic controlling switch.Cell Stress Chaperones.2024;29:175-200.

[156] Desroches Altamirano C,Alberti S.Surviving the heat: the role of macromolecular assemblies in promoting cellular shutdown.Trends Biochem Sci.2025;50:18-32.

[157] Kepp KP,Dasmeh P.A model of proteostatic energy cost and its use in analysis of proteome trends and sequence evolution.PLoS One.2014;9:e90504.

[158] Rolfe DF,Brown GC.Cellular energy utilization and molecular origin of standard metabolic rate in mammals.Physiol Rev.1997;77:731-58.

[159] Sharma SK,De los Rios P,Christen P,Lustig A,Goloubinoff P.The kinetic parameters and energy cost of the Hsp70 chaperone as a polypeptide unfoldase.Nat Chem Biol.2010;6:914-20.

[160] Wisniewska M,Karlberg T,Lehtiö L,Johansson I,Kotenyova T,Moche M,et al.Crystal structures of the ATPase domains of four human Hsp70 isoforms: HSPA1L/Hsp70-hom, HSPA2/Hsp70-2, HSPA6/Hsp70B’, and HSPA5/BiP/GRP78.PLoS One.2010;5:e8625.

[161] Feder ME,Hofmann GE.Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology.Annu Rev Physiol.1999;61:243-82.

[162] Dobson CM.Protein misfolding, evolution and disease.Trends Biochem Sci.1999;24:329-32.

[163] Sulatsky MI,Stepanenko OV,Stepanenko OV,Povarova OI,Kuznetsova IM,Turoverov KK,et al.Broken but not beaten: Challenge of reducing the amyloids pathogenicity by degradation.J Adv Res.2025;70:45-62.

[164] Sulatskaya AI,Rychkov GN,Sulatsky MI,Mikhailova EV,Melnikova NM,Andozhskaya VS,et al.New Evidence on a Distinction between Aβ40 and Aβ42 Amyloids: Thioflavin T Binding Modes, Clustering Tendency, Degradation Resistance, and Cross-Seeding.Int J Mol Sci.2022;23:5513.

[165] Nachman E,Wentink AS,Madiona K,Bousset L,Katsinelos T,Allinson K,et al.Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species.J Biol Chem.2020;295:9676-90.

[166] Wentink AS,Nillegoda NB,Feufel J,Ubartaitė G,Schneider CP,De Los Rios P,et al.Molecular dissection of amyloid disaggregation by human HSP70.Nature.2020;587:483-8.

[167] Franco A,Gracia P,Colom A,Camino JD,Fernández-Higuero JÁ,Orozco N,et al.All-or-none amyloid disassembly via chaperone-triggered fibril unzipping favors clearance of α-synuclein toxic species.Proc Natl Acad Sci U S A.2021;118:e2105548118.

[168] De Los Rios P,Barducci A.Hsp70 chaperones are non-equilibrium machines that achieve ultra-affinity by energy consumption.Elife.2014;3:e02218.

[169] Gracia P,Camino JD,Volpicelli-Daley L,Cremades N.Multiplicity of α-Synuclein Aggregated Species and Their Possible Roles in Disease.Int J Mol Sci.2020;21:8043.

[170] McCarty JS,Buchberger A,Reinstein J,Bukau B.The role of ATP in the functional cycle of the DnaK chaperone system.J Mol Biol.1995;249:126-37.

[171] Tittelmeier J,Sandhof CA,Ries HM,Druffel-Augustin S,Mogk A,Bukau B,et al.The HSP110/HSP70 disaggregation system generates spreading-competent toxic α-synuclein species.EMBO J.2020;39:e103954.

[172] Dragovic Z,Broadley SA,Shomura Y,Bracher A,Hartl FU.Molecular chaperones of the Hsp110 family act as nucleotide exchange factors of Hsp70s.EMBO J.2006;25:2519-28.

[173] Labrador-Garrido A,Cejudo-Guillén M,Klippstein R,De Genst EJ,Tomas-Gallardo L,Leal MM,et al.Chaperoned amyloid proteins for immune manipulation: α-Synuclein/Hsp70 shifts immunity toward a modulatory phenotype.Immun Inflamm Dis.2014;2:226-38.

[174] Hoekstra LA,Montooth KL.Inducing extra copies of the Hsp70 gene in Drosophila melanogaster increases energetic demand.BMC Evol Biol.2013;13:68.

[175] Morrone CD,Raghuraman R,Hussaini SA,Yu WH.Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer’s disease.Mol Neurodegener.2023;18:27.

[176] Bruni AC,Bernardi L,Gabelli C.From beta amyloid to altered proteostasis in Alzheimer’s disease.Ageing Res Rev.2020;64:101126.

[177] Radwan M,Wood RJ,Sui X,Hatters DM.When proteostasis goes bad: Protein aggregation in the cell.IUBMB Life.2017;69:49-54.

[178] Hipp MS,Kasturi P,Hartl FU.The proteostasis network and its decline in ageing.Nat Rev Mol Cell Biol.2019;20:421-35.

[179] Reynolds NP,Adamcik J,Berryman JT,Handschin S,Zanjani AAH,Li W,et al.Competition between crystal and fibril formation in molecular mutations of amyloidogenic peptides.Nat Commun.2017;8:1338.

[180] Trcka F,Durech M,Vankova P,Chmelik J,Martinkova V,Hausner J,et al.Human Stress-inducible Hsp70 Has a High Propensity to Form ATP-dependent Antiparallel Dimers That Are Differentially Regulated by Cochaperone Binding.Mol Cell Proteomics.2019;18:320-37.

[181] Riback JA,Katanski CD,Kear-Scott JL,Pilipenko EV,Rojek AE,Sosnick TR,et al.Stress-Triggered Phase Separation Is an Adaptive, Evolutionarily Tuned Response.Cell.2017;168:1028-40.e19.

[182] Ozacmak VH,Barut F,Ozacmak HS.Melatonin provides neuroprotection by reducing oxidative stress and HSP70 expression during chronic cerebral hypoperfusion in ovariectomized rats.J Pineal Res.2009;47:156-63.

[183] Yamada K,Iwatsubo T.Involvement of the glymphatic/meningeal lymphatic system in Alzheimer’s disease: insights into proteostasis and future directions.Cell Mol Life Sci.2024;81:192.

[184] Verheggen ICM,Van Boxtel MPJ,Verhey FRJ,Jansen JFA,Backes WH.Interaction between blood-brain barrier and glymphatic system in solute clearance.Neurosci Biobehav Rev.2018;90:26-33.

[185] Makin OS,Atkins E,Sikorski P,Johansson J,Serpell LC.Molecular basis for amyloid fibril formation and stability.Proc Natl Acad Sci U S A.2005;102:315-20.

[186] Goto Y,Nakajima K,Yamamoto S,Yamaguchi K.Supersaturation, a Critical Factor Underlying Proteostasis of Amyloid Fibril Formation.J Mol Biol.2024;436:168475.

[187] Jessen NA,Munk AS,Lundgaard I,Nedergaard M.The Glymphatic System: A Beginner’s Guide.Neurochem Res.2015;40:2583-99.

[188] Sturchio A,Dwivedi AK,Young CB,Malm T,Marsili L,Sharma JS,et al.High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis.EClinicalMedicine.2021;38:100988.

[189] Loeffler DA.Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems.J Alzheimers Dis.2024;100:379-411.

[190] Wichmann TO,Damkier HH,Pedersen M.A Brief Overview of the Cerebrospinal Fluid System and Its Implications for Brain and Spinal Cord Diseases.Front Hum Neurosci.2022;15:737217.

[191] Kaur J,Fahmy LM,Davoodi-Bojd E,Zhang L,Ding G,Hu J,et al.Waste Clearance in the Brain.Front Neuroanat.2021;15:665803.

[192] Louveau A,Plog BA,Antila S,Alitalo K,Nedergaard M,Kipnis J.Understanding the functions and relationships of the glymphatic system and meningeal lymphatics.J Clin Invest.2017;127:3210-9.

[193] Smyth LCD,Beschorner N,Nedergaard M,Kipnis J.Cellular Contributions to Glymphatic and Lymphatic Waste Clearance in the Brain.Cold Spring Harb Perspect Biol.2024;[Epub ahead of print]

[194] van Veluw SJ,Benveniste H,van Osch MJPLeducq Foundation Transatlantic Network of Excellence on Brain Clearance.A translational approach towards understanding brain waste clearance in cerebral amyloid angiopathy.Eur Heart J.2024;45:1500-2.

[195] Chen X,Liu X,Koundal S,Elkin R,Zhu X,Monte B,et al.Cerebral amyloid angiopathy is associated with glymphatic transport reduction and time-delayed solute drainage along the neck arteries.Nat Aging.2022;2:214-23.

[196] Harrison IF,Ismail O,Machhada A,Colgan N,Ohene Y,Nahavandi P,et al.Impaired glymphatic function and clearance of tau in an Alzheimer’s disease model.Brain.2020;143:2576-93.

[197] Ligocki AP,Vinson AV,Yachnis AT,Dunn WA Jr,Smith DE,Scott EA,et al.Cerebrospinal fluid flow extends to peripheral nerves further unifying the nervous system.Sci Adv.2024;10:eadn3259.

[198] Hladky SB,Barrand MA.The glymphatic hypothesis: the theory and the evidence.Fluids Barriers CNS.2022;19:9.

[199] Ringstad G,Eide PK.Glymphatic-lymphatic coupling: assessment of the evidence from magnetic resonance imaging of humans.Cell Mol Life Sci.2024;81:131.

[200] Pemberton HG,Collij LE,Heeman F,Bollack A,Shekari M,Salvadó G,et al.AMYPAD consortium.Quantification of amyloid PET for future clinical use: a state-of-the-art review.Eur J Nucl Med Mol Imaging.2022;49:3508-28.

[201] Huang SY,Zhang YR,Guo Y,Du J,Ren P,Wu BS,et al.Alzheimer’s Disease Neuroimaging InitiativeCheng W,Yu JT.Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer’s disease.Alzheimers Dement.2024;20:3251-69.

[202] Iliff JJ,Elbert DL,Giovangrandi L,Singh T,Venkatesh VV,Corbellini A,et al.The glymphatic system clears amyloid beta and tau from brain to plasma in humansmedRxiv 2024.07.30.24311248 [Preprint]. 2024 [cited 2024 Dec 4]. Available from: https://doi.org/10.1101/2024.07.30.24311248

[203] Zhou L,Butler TA,Wang XH,Xi K,Tanzi EB,Glodzik L,et al.Multimodal assessment of brain fluid clearance is associated with amyloid-beta deposition in humans.J Neuroradiol.2024;51:101164.

[204] Wu L,Zhang Z,Liang X,Wang Y,Cao Y,Li M,et al.Glymphatic system dysfunction in recovered patients with mild COVID-19: A DTI-ALPS study.iScience.2024;27:108647.

[205] Chaganti JR,Talekar TK,Brew BJ.Asymmetrical glymphatic dysfunction in patients with Long Covid associated neurocognitive impairment- Correlation with BBB disruptionResearch Square [Preprint]. 2024 [cited 2024 Dec 4]. Available from: https://doi.org/10.21203/rs.3.rs-4551571/v1

[206] Dijk DJ.Regulation and functional correlates of slow wave sleep.J Clin Sleep Med.2009;5:S6-15.

[207] Dijk DJ,Shanahan TL,Duffy JF,Ronda JM,Czeisler CA.Variation of electroencephalographic activity during non-rapid eye movement and rapid eye movement sleep with phase of circadian melatonin rhythm in humans.J Physiol.1997;505:851-8.

[208] Ukraintseva YV,Saltykov KA.Effects of Fragmentation of Stage 3 Sleep and Rapid Eye Movement Sleep on Melatonin Secretion.Neurosci Behav Physiol.2024;54:955-60.

[209] Ukraintseva YV,Liaukovich KM,Saltykov KA,Belov DA,Nizhnik АN.Selective slow-wave sleep suppression affects glucose tolerance and melatonin secretion. The role of sleep architecture.Sleep Med.2020;67:171-83.

[210] Nishi T,Saeki K,Miyata K,Yoshikawa T,Ueda T,Kurumatani N,et al.Effects of Cataract Surgery on Melatonin Secretion in Adults 60 Years and Older: A Randomized Clinical Trial.JAMA Ophthalmol.2020;138:405-11.

[211] Delle C,Wang X,Nedergaard M.The Ocular Glymphatic System-Current Understanding and Future Perspectives.Int J Mol Sci.2024;25:5734.

[212] Reiter RJ,Sharma R,Rosales-Corral S,de Mange J,Phillips WT,Tan DX,et al.Melatonin in ventricular and subarachnoid cerebrospinal fluid: Its function in the neural glymphatic network and biological significance for neurocognitive health.Biochem Biophys Res Commun.2022;605:70-81.

[213] Skinner DC,Malpaux B.High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus.Endocrinology.1999;140:4399-405.

[214] Kanematsu N,Mori Y,Hayashi S,Hoshino K.Presence of a distinct 24-hour melatonin rhythm in the ventricular cerebrospinal fluid of the goat.J Pineal Res.1989;7:143-52.

[215] Hedlund L,Lischko MM,Rollag MD,Niswender GD.Melatonin: daily cycle in plasma and cerebrospinal fluid of calves.Science.1977;195:686-7.

[216] Semyachkina-Glushkovskaya O,Fedosov I,Penzel T,Li D,Yu T,Telnova V,et al.Brain Waste Removal System and Sleep: Photobiomodulation as an Innovative Strategy for Night Therapy of Brain Diseases.Int J Mol Sci.2023;24:3221.

[217] Eide PK,Vinje V,Pripp AH,Mardal KA,Ringstad G.Sleep deprivation impairs molecular clearance from the human brain.Brain.2021;144:863-74.

[218] Xie L,Kang H,Xu Q,Chen MJ,Liao Y,Thiyagarajan M,et al.Sleep drives metabolite clearance from the adult brain.Science.2013;342:373-7.

[219] Reiter RJ,Sharma R,Cucielo MS,Tan DX,Rosales-Corral S,Gancitano G,et al.Brain washing and neural health: role of age, sleep, and the cerebrospinal fluid melatonin rhythm.Cell Mol Life Sci.2023;80:88.

[220] Bitar RD,Torres-Garza JL,Reiter RJ,Phillips WT.Neural glymphatic system: Clinical implications and potential importance of melatonin.Melatonin Res.2021;4:551-65.

[221] Mineiro R,Rodrigues Cardoso M,Catarina Duarte A,Santos C,Cipolla-Neto J,Gaspar do Amaral F,et al.Melatonin and brain barriers: The protection conferred by melatonin to the blood-brain barrier and blood-cerebrospinal fluid barrier.Front Neuroendocrinol.2024;75:101158.

[222] Zhou JN,Liu RY,Kamphorst W,Hofman MA,Swaab DF.Early neuropathological Alzheimer’s changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels.J Pineal Res.2003;35:125-30.

[223] Liu RY,Zhou JN,van Heerikhuize J,Hofman MA,Swaab DF.Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer’s disease, and apolipoprotein E-ε4/4 genotype.J Clin Endocrinol Metab.1999;84:323-7.

[224] Wu YH,Feenstra MG,Zhou JN,Liu RY,Toranõ JS,Van Kan HJ,et al.Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages.J Clin Endocrinol Metab.2003;88:5898-906.

[225] Georgieva I,Tchekalarova J,Nenchovska Z,Kortenska L,Tzoneva R.Melatonin Supplementation Alleviates Impaired Spatial Memory by Influencing Aβ_1-42 Metabolism via γ-Secretase in the icvAβ_1-42 Rat Model with Pinealectomy.Int J Mol Sci.2024;25:10294.

[226] Tchekalarova J,Ivanova P,Krushovlieva D,Kortenska L,Angelova VT.Protective Effect of the Novel Melatonin Analogue Containing Donepezil Fragment on Memory Impairment via MT/ERK/CREB Signaling in the Hippocampus in a Rat Model of Pinealectomy and Subsequent Aβ_1-42 Infusion.Int J Mol Sci.2024;25:1867.

[227] Tzoneva R,Georgieva I,Ivanova N,Uzunova V,Nenchovska Z,Apostolova S,et al.The Role of Melatonin on Behavioral Changes and Concomitant Oxidative Stress in icvAβ_1-42 Rat Model with Pinealectomy.Int J Mol Sci.2021;22:12763.

[228] Song J.Pineal gland dysfunction in Alzheimer’s disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis.Mol Neurodegener.2019;14:28.

[229] De Butte M,Pappas BA.Pinealectomy causes hippocampal CA1 and CA3 cell loss: reversal by melatonin supplementation.Neurobiol Aging.2007;28:306-13.

[230] Mohammadi S,Zahmatkesh M,Asgari Y,Aminyavari S,Hassanzadeh G.Evaluation of hippocampal arylalkylamine N-acetyltransferase activity in amyloid-β neurotoxicity.J Mol Endocrinol.2023;71:e220161.

[231] Ghorbandaiepour T,Sadroddiny E,Zahmatkesh M,Hassanzadeh G.Inhibition of hippocampal melatonin synthesis by siRNA induced learning and memory deficits in male rats.Horm Behav.2024;164:105599.

[232] Ortiz-Vega N,Lobato AG,Canic T,Zhu Y,Lazopulo S,Syed S,et al.Regulation of proteostasis by sleep through autophagy in Drosophila models of Alzheimer’s disease.Life Sci Alliance.2024;7:e202402681.

[233] Sanislav O,Tetaj R,MetaliRatcliffe J,Phillips W,Klein AR,et al.Cell invasive amyloid assemblies from SARS-CoV-2 peptides can form multiple polymorphs with varying neurotoxicity.Nanoscale.2024;16:19814-27.

[234] Du Y,Li C,Zhao W,Li J,Zhao L,Guo H,et al.Multimodal neuroimaging exploration of the mechanisms of sleep quality deterioration after SARS-CoV-2 Omicron infection.BMC Med.2024;22:271.

[235] Yao D,Li R,Hao J,Huang H,Wang X,Ran L,et al.Melatonin alleviates depression-like behaviors and cognitive dysfunction in mice by regulating the circadian rhythm of AQP4 polarization.Transl Psychiatry.2023;13:310.

[236] Gáll Z,Boros B,Kelemen K,Urkon M,Zolcseak I,Márton K,et al.Melatonin improves cognitive dysfunction and decreases gliosis in the streptozotocin-induced rat model of sporadic Alzheimer’s disease.Front Pharmacol.2024;15:1447757.

[237] Andrade MK,Souza LC,Azevedo EM,Bail EL,Zanata SM,Andreatini R,et al.Melatonin reduces β-amyloid accumulation and improves short-term memory in streptozotocin-induced sporadic Alzheimer’s disease model.IBRO Neurosci Rep.2023;14:264-72.

[238] Fan L,Zhaohong X,Xiangxue W,Yingying X,Xiao Z,Xiaoyan Z,et al.Melatonin Ameliorates the Progression of Alzheimer’s Disease by Inducing TFEB Nuclear Translocation, Promoting Mitophagy, and Regulating NLRP3 Inflammasome Activity.Biomed Res Int.2022;2022:8099459.

[239] Balmik AA,Das R,Dangi A,Gorantla NV,Marelli UK,Chinnathambi S.Melatonin interacts with repeat domain of Tau to mediate disaggregation of paired helical filaments.Biochim Biophys Acta Gen Subj.2020;1864:129467.

[240] Das R,Balmik AA,Chinnathambi S.Effect of Melatonin on Tau aggregation and Tau-mediated cell surface morphology.Int J Biol Macromol.2020;152:30-9.

[241] Luengo E,Buendia I,Fernández-Mendívil C,Trigo-Alonso P,Negredo P,Michalska P,et al.Pharmacological doses of melatonin impede cognitive decline in tau-related Alzheimer models, once tauopathy is initiated, by restoring the autophagic flux.J Pineal Res.2019;67:e12578.

[242] Pappolla MA,Matsubara E,Vidal R,Pacheco-Quinto J,Poeggeler B,Zagorski M,et al.Melatonin Treatment Enhances Aβ Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis.Curr Alzheimer Res.2018;15:637-42.

[243] Ali T,Kim MO.Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus.J Pineal Res.2015;59:47-59.

[244] Ono K,Mochizuki H,Ikeda T,Nihira T,Takasaki J,Teplow DB,et al.Effect of melatonin on α-synuclein self-assembly and cytotoxicity.Neurobiol Aging.2012;33:2172-85.

[245] Masilamoni JG,Jesudason EP,Dhandayuthapani S,Ashok BS,Vignesh S,Jebaraj WC,et al.The neuroprotective role of melatonin against amyloid beta peptide injected mice.Free Radic Res.2008;42:661-73.

[246] Lin AMY,Fang SF,Chao PL,Yang CH.Melatonin attenuates arsenite-induced apoptosis in rat brain: involvement of mitochondrial and endoplasmic reticulum pathways and aggregation of α-synuclein.J Pineal Res.2007;43:163-71.

[247] Quinn J,Kulhanek D,Nowlin J,Jones R,Praticò D,Rokach J,et al.Chronic melatonin therapy fails to alter amyloid burden or oxidative damage in old Tg2576 mice: implications for clinical trials.Brain Res.2005;1037:209-13.

[248] Lahiri DK,Chen D,Ge YW,Bondy SC,Sharman EH.Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex.J Pineal Res.2004;36:224-31.

[249] Matsubara E,Bryant-Thomas T,Pacheco Quinto J,Henry TL,Poeggeler B,Herbert D,et al.Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer’s disease.J Neurochem.2003;85:1101-8.

[250] Skribanek Z,Baláspiri L,Mák M.Interaction between synthetic amyloid-β-peptide (1–40) and its aggregation inhibitors studied by electrospray ionization mass spectrometry.J Mass Spectrom.2001;36:1226-9.

[251] Pappolla M,Bozner P,Soto C,Shao H,Robakis NK,Zagorski M,et al.Inhibition of Alzheimer β-fibrillogenesis by melatonin.J Biol Chem.1998;273:7185-8.

[252] Barrow ER,Valionyte E,Baxter CR,Yang Y,Herath S,O’Connell WA,et al.Discovery of SQSTM1/p62-dependent P-bodies that regulate the NLRP3 inflammasome.Cell Rep.2024;43:113935.

[253] Wang Z,Chen D,Guan D,Liang X,Xue J,Zhao H,et al.Material properties of phase-separated TFEB condensates regulate the autophagy-lysosome pathway.J Cell Biol.2022;221:e202112024.

[254] Zarándi M,Soós K,Fülöp L,Bozsó Z,Datki Z,Tóth GK,et al.Synthesis of Aβ[1-42] and its derivatives with improved efficiency.J Peptide Sci.2007;13:94-9.

[255] Nirmalraj PN,Bhattacharya S,Thompson D.Accelerated Alzheimer’s Aβ-42 secondary nucleation chronologically visualized on fibril surfaces.Sci Adv.2024;10:eadp5059.

[256] Johan K,Westermark G,Engström U,Gustavsson A,Hultman P,Westermark P.Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils.Proc Natl Acad Sci U S A.1998;95:2558-63.

[257] Walsh DM,Thulin E,Minogue AM,Gustavsson N,Pang E,Teplow DB,et al.A facile method for expression and purification of the Alzheimer’s disease-associated amyloid β-peptide.FEBS J.2009;276:1266-81.

[258] Mukherjee S,Ramos S,Pezzotti S,Kalarikkal A,Prass TM,Galazzo L,et al.Entropy Tug-of-War Determines Solvent Effects in the Liquid–Liquid Phase Separation of a Globular Protein.J Phys Chem Lett.2024;15:4047-55.

[259] Park S,Barnes R,Lin Y,Jeon BJ,Najafi S,Delaney KT,et al.Dehydration entropy drives liquid-liquid phase separation by molecular crowding.Commun Chem.2020;3:83.

[260] Conti Nibali V,Pezzotti S,Sebastiani F,Galimberti DR,Schwaab G,Heyden M,et al.Wrapping Up Hydrophobic Hydration: Locality Matters.J Phys Chem Lett.2020;11:4809-16.

[261] Camino JD,Gracia P,Cremades N.The role of water in the primary nucleation of protein amyloid aggregation.Biophys Chem.2021;269:106520.

[262] Ohgita T,Kono H,Namba N,Saito H.Physicochemical mechanisms of aggregation and fibril formation of α-synuclein and apolipoprotein A-I.Biophys Physicobiol.2024;21:e210005.

[263] Zhou R,Huang X,Margulis CJ,Berne BJ.Hydrophobic collapse in multidomain protein folding.Science.2004;305:1605-9.

[264] Thirumalai D,Reddy G,Straub JE.Role of water in protein aggregation and amyloid polymorphism.Acc Chem Res.2012;45:83-92.

[265] Klement K,Wieligmann K,Meinhardt J,Hortschansky P,Richter W,Fändrich M.Effect of different salt ions on the propensity of aggregation and on the structure of Alzheimer’s Aβ(1-40) amyloid fibrils.J Mol Biol.2007;373:1321-33.

[266] Islam M,Shen F,Regmi D,Petersen K,Karim MRU,Du D.Tau liquid–liquid phase separation: At the crossroads of tau physiology and tauopathy.J Cell Physiol.2024;239:e30853.

[267] Lin Y,Fichou Y,Longhini AP,Llanes LC,Yin P,Bazan GC,et al.Liquid-Liquid Phase Separation of Tau Driven by Hydrophobic Interaction Facilitates Fibrillization of Tau.J Mol Biol.2021;433:166731.

[268] Ono K,Hamaguchi T,Naiki H,Yamada M.Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer’s disease.Biochim Biophys Acta.2006;1762:575-86.

[269] Vultaggio-Poma V,Scussel Bergamin L,Falzoni S,Tarantini M,Giuliani AL,Sandonà D,et al.Fetal bovine serum contains biologically available ATP.Purinergic Signal.2024;20:83-9.

[270] LePage KT,Dickey RW,Gerwick WH,Jester EL,Murray TF.On the use of neuro-2a neuroblastoma cells versus intact neurons in primary culture for neurotoxicity studies.Crit Rev Neurobiol.2005;17:27-50.

[271] Genc S,Kurnaz IA,Ozilgen M.Astrocyte - neuron lactate shuttle may boost more ATP supply to the neuron under hypoxic conditions - in silico study supported by in vitro expression data.BMC Syst Biol.2011;5:162.

[272] Nguyen NT,Ooi L,Piller SC,Münch G.Proenergetic effects of resveratrol in the murine neuronal cell line Neuro2a.Mol Nutr Food Res.2013;57:1901-7.

[273] Kronenberger L,Mett J,Hoppstädter J,Müller U.Metabolic Profiling of SH-SY5Y and Neuro2A Cells in Relation to Fetal Calf Serum (FCS) Concentration in Culture Media.Metabolites.2024;14:188.

[274] Calkins MJ,Manczak M,Mao P,Shirendeb U,Reddy PH.Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer’s disease.Hum Mol Genet.2011;20:4515-29.

[275] Mandl I,Grauer A,Neuberg C.Solubilization of insoluble matter in nature: I. The part played by salts of adenosinetriphosphate.Biochim Biophys Acta.1952;8:654-63.

[276] Patel A,Malinovska L,Saha S,Wang J,Alberti S,Krishnan Y,et al.ATP as a biological hydrotrope.Science.2017;356:753-6.

[277] Hayes MH,Peuchen EH,Dovichi NJ,Weeks DL.Dual roles for ATP in the regulation of phase separated protein aggregates in Xenopus oocyte nucleoli.Elife.2018;7:e35224.

[278] Song J.Adenosine Triphosphate: The Primordial Molecule That Controls Protein Homeostasis and Shapes the Genome-Proteome Interface.Biomolecules.2024;14:500.

[279] Song J.Adenosine triphosphate energy-independently controls protein homeostasis with unique structure and diverse mechanisms.Protein Sci.2021;30:1277-93.

[280] Maguire OR,Smokers IBA,Oosterom BG,Zheliezniak A,Huck WTS.A Prebiotic Precursor to Life’s Phosphate Transfer System with an ATP Analog and Histidyl Peptide Organocatalysts.J Am Chem Soc.2024;146:7839-49.

[281] Hautke A,Ebbinghaus S.The emerging role of ATP as a cosolute for biomolecular processes.Biol Chem.2023;404:897-908.

[282] Nishizawa M,Walinda E,Morimoto D,Kohn B,Scheler U,Shirakawa M,et al.Effects of Weak Nonspecific Interactions with ATP on Proteins.J Am Chem Soc.2021;143:11982-93.

[283] Kang J,Lim L,Song J.ATP induces folding of ALS-causing C71G-hPFN1 and nascent hSOD1.Commun Chem.2023;6:186.

[284] Heo CE,Han JY,Lim S,Lee J,Im D,Lee MJ,et al.ATP Kinetically Modulates Pathogenic Tau Fibrillations.ACS Chem Neurosci.2020;11:3144-52.

[285] Dec R,Puławski W,Dzwolak W.Selective and stoichiometric incorporation of ATP by self-assembling amyloid fibrils.J Mater Chem B.2021;9:8626-30.

[286] Do TM,Horinek D,Matubayasi N.How ATP suppresses the fibrillation of amyloid peptides: analysis of the free-energy contributions.Phys Chem Chem Phys.2024;26:11880-92.

[287] Dang M,Li Y,Song J.ATP biphasically modulates LLPS of SARS-CoV-2 nucleocapsid protein and specifically binds its RNA-binding domain.Biochem Biophys Res Commun.2021;541:50-5.

[288] Zhu Y,Lin S,Meng L,Sun M,Liu M,Li J,et al.ATP promotes protein coacervation through conformational compaction.J Mol Cell Biol.2024;16:mjae038.

[289] Kamski-Hennekam ER,Huang J,Ahmed R,Melacini G.Toward a molecular mechanism for the interaction of ATP with alpha-synuclein.Chem Sci.2023;14:9933-42.

[290] Dec R,Dzwolak W,Winter R.From a Droplet to a Fibril and from a Fibril to a Droplet: Intertwined Transition Pathways in Highly Dynamic Enzyme-Modulated Peptide-Adenosine Triphosphate Systems.J Am Chem Soc.2024;146:6045-52.

[291] Coskuner O,Murray IV.Adenosine triphosphate (ATP) reduces amyloid-β protein misfolding in vitro.J Alzheimers Dis.2014;41:561-74.

[292] Mehringer J,Do TM,Touraud D,Hohenschutz M,Khoshsima A,Horinek D,et al.Hofmeister versus Neuberg: is ATP really a biological hydrotrope?Cell Rep Phys Sci.2021;2:100343.

[293] Mogami G,Wazawa T,Morimoto N,Kodama T,Suzuki M.Hydration properties of adenosine phosphate series as studied by microwave dielectric spectroscopy.Biophys Chem.2011;154:1-7.

[294] Kang J,Lim L,Song J.ATP binds and inhibits the neurodegeneration-associated fibrillization of the FUS RRM domain.Commun Biol.2019;2:223.

[295] Kuramochi M,Nakamura M,Takahashi H,Komoriya T,Takita T,Pham NTK,et al.Adenosine triphosphate induces amorphous aggregation of amyloid β by increasing Aβ dynamics.Sci Rep.2024;14:8134.

[296] Pal S,Paul S.ATP Controls the Aggregation of Aβ_16–22 Peptides.J Phys Chem B.2020;124:210-23.

[297] Greiner JV,Glonek T.Intracellular ATP Concentration and Implication for Cellular Evolution.Biology (Basel).2021;10:1166.

[298] Sarkar S,Gupta S,Mahato C,Das D,Mondal J.Elucidating ATP’s role as solubilizer of biomolecular aggregate.Elife.2024;13:RP99150.

[299] Kang K,Lee K,Park S,Byeon Y,Back K.Molecular cloning of rice serotonin N-acetyltransferase, the penultimate gene in plant melatonin biosynthesis.J Pineal Res.2013;55:7-13.

[300] Coon SL,Weller JL,Korf HW,Namboodiri MA,Rollag M,Klein DC.cAmp regulation of arylalkylamine N-acetyltransferase (AANAT, EC 2.3.1.87): a new cell line (1E7) provides evidence of intracellular AANAT activation.J Biol Chem.2001;276:24097-107.

[301] Vonck J,Pisa KY,Morgner N,Brutschy B,Müller V.Three-dimensional structure of A₁A₀ ATP synthase from the hyperthermophilic archaeon Pyrococcus furiosus by electron microscopy.J Biol Chem.2009;284:10110-9.

[302] Rabbers I,Bruggeman FJ.Escherichia coli robustly expresses ATP synthase at growth rate-maximizing concentrations.FEBS J.2022;289:4925-34.

[303] He J,Ford HC,Carroll J,Douglas C,Gonzales E,Ding S,et al.Assembly of the membrane domain of ATP synthase in human mitochondria.Proc Natl Acad Sci U S A.2018;115:2988-93.

[304] Gagat P,Mackiewicz D,Mackiewicz P.Peculiarities within peculiarities – dinoflagellates and their mitochondrial genomes.Mitochondrial DNA B Resour.2017;2:191-5.

[305] Fuhrberg B,Hardeland R,Poeggeler B,Behrmann C.Dramatic Rises of Melatonin and 5-Methoxytryptamine in Gonyaulax Exposed to Decreased Temperature.Biol Rhythm Res.1997;28:144-50.

[306] Zhang C,Rissman RA,Feng J.Characterization of ATP alternations in an Alzheimer’s disease transgenic mouse model.J Alzheimers Dis.2015;44:375-8.

[307] Ritwiset A,Khajonrit J,Krongsuk S,Maensiri S.Molecular insight on the formation structure and dynamics of melatonin in an aqueous solution and at the Water-Air interface: A molecular dynamics study.J Mol Graph Model.2021;108:107983.

[308] Rodrigues ACC,de M.Camargo LTF, Francisco Lopes Y, Sallum LO, Napolitano HB, Camargo AJ. Aqueous solvation study of melatonin using ab initio molecular dynamics.J Mol Liq.2021;343:117451.

[309] Florio GM,Zwier TS.Solvation of a Flexible Biomolecule in the Gas Phase:  The Ultraviolet and Infrared Spectroscopy of Melatonin−Water Clusters.J Phys Chem A.2003;107:974-83.

[310] Purushothaman A,Sheeja AA,Janardanan D.Hydroxyl radical scavenging activity of melatonin and its related indolamines.Free Radic Res.2020;54:373-83.

[311] Al-Zaqri N,Pooventhiran T,Alsalme A,Warad I,John AM,Thomas R.Structural and physico-chemical evaluation of melatonin and its solution-state excited properties, with emphasis on its binding with novel coronavirus proteins.J Mol Liq.2020;318:114082.

[312] Melatonin [Internet]Bethesda: Courtesy of the National Library of Medicine; [cited 2023 Jan 7]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Melatonin

[313] Adenosine Triphosphate [Internet]Bethesda: Courtesy of the National Library of Medicine; [cited 2024 Apr 18]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/5957

[314] Patel V,Mill J,Okonkwo OC,Salamat S,Li L,Raife T.Global Energy Metabolism Deficit in Alzheimer Disease Brain.J Prev Alzheimers Dis.2024;11:171-8.

[315] Ježek P,Dlasková A,Engstová H,Špačková J,Tauber J,Průchová P,et al.Mitochondrial Physiology of Cellular Redox Regulations.Physiol Res.2024;73:S217-42.

[316] Stein LR,Imai S.The dynamic regulation of NAD metabolism in mitochondria.Trends Endocrinol Metab.2012;23:420-8.

[317] Harris JJ,Jolivet R,Attwell D.Synaptic energy use and supply.Neuron.2012;75:762-77.

[318] Dworak M,McCarley RW,Kim T,Kalinchuk AV,Basheer R.Sleep and brain energy levels: ATP changes during sleep.J Neurosci.2010;30:9007-16.

[319] Sun X,Dias L,Peng C,Zhang Z,Ge H,Wang Z,et al.40 Hz light flickering facilitates the glymphatic flow via adenosine signaling in mice.Cell Discov.2024;10:81.

[320] Sarnataro R,Velasco CD,Monaco N,Kempf A,Miesenböck G.Mitochondrial origins of the pressure to sleepbioRxiv 2024.02.23.581770 [Preprint]. 2024 [cited 2024 Dec 4]. Available from: https://doi.org/10.1101/2024.02.23.581770

[321] Hasenhuetl PS,Sarnataro R,Vrontou E,Rorsman HO,Talbot CB,Brain R,et al.A half-center oscillator encodes sleep pressurebioRxiv 2024.02.23.581780 [Preprint]. 2024 [cited 2024 Dec 4]. Available from: https://doi.org/10.1101/2024.02.23.581780

[322] Kopeć K,Szleszkowski S,Koziorowski D,Szlufik S.Glymphatic System and Mitochondrial Dysfunction as Two Crucial Players in Pathophysiology of Neurodegenerative Disorders.Int J Mol Sci.2023;24:10366.

[323] Cruz-Sanabria F,Carmassi C,Bruno S,Bazzani A,Carli M,Scarselli M,et al.Melatonin as a Chronobiotic with Sleep-promoting Properties.Curr Neuropharmacol.2023;21:951-87.

[324] Salloway S,Chalkias S,Barkhof F,Burkett P,Barakos J,Purcell D,et al.Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease.JAMA Neurol.2022;79:13-21.

[325] Budd Haeberlein S,Aisen PS,Barkhof F,Chalkias S,Chen T,Cohen S,et al.Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease.J Prev Alzheimers Dis.2022;9:197-210.

[326] Wojtunik-Kulesza K,Rudkowska M,Orzeł-Sajdłowska A.Aducanumab-Hope or Disappointment for Alzheimer’s Disease.Int J Mol Sci.2023;24:4367.

[327] Heidebrink JL,Paulson HL.Lessons Learned from Approval of Aducanumab for Alzheimer’s Disease.Annu Rev Med.2024;75:99-111.

[328] Kaku T,Ikebukuro K,Tsukakoshi K.Structure of cytotoxic amyloid oligomers generated during disaggregation.J Biochem.2024;175:575-85.

[329] Xue WF,Hellewell AL,Gosal WS,Homans SW,Hewitt EW,Radford SE.Fibril fragmentation enhances amyloid cytotoxicity.J Biol Chem.2009;284:34272-82.

[330] Bucciantini M,Calloni G,Chiti F,Formigli L,Nosi D,Dobson CM,et al.Prefibrillar amyloid protein aggregates share common features of cytotoxicity.J Biol Chem.2004;279:31374-82.

[331] Bissig C,Rochin L,van Niel G.PMEL Amyloid Fibril Formation: The Bright Steps of Pigmentation.Int J Mol Sci.2016;17:1438.

[332] Maji SK,Perrin MH,Sawaya MR,Jessberger S,Vadodaria K,Rissman RA,et al.Functional amyloids as natural storage of peptide hormones in pituitary secretory granules.Science.2009;325:328-32.

[333] Myers C,Hastert MC,Cornwall GA.Host defense functions of the epididymal amyloid matrix.Mol Hum Reprod.2022;28:gaac038.

[334] Tang Y,Zhang Y,Zhang D,Liu Y,Nussinov R,Zheng J.Exploring pathological link between antimicrobial and amyloid peptides.Chem Soc Rev.2024;53:8713-63.

[335] Dresser LG,Leake MC,Quinn SD.Beta-amyloid induces the structural remodeling of single-lipid vesicles.Biophys J.2024;123:506a-7a.

[336] Sepehri A,Lazaridis T.Putative Structures of Membrane-Embedded Amyloid β Oligomers.ACS Chem Neurosci.2023;14:99-110.

[337] Sciacca MFM,La Rosa C,Milardi D.Amyloid-Mediated Mechanisms of Membrane Disruption.Biophysica.2021;1:137-56.

[338] Soscia SJ,Kirby JE,Washicosky KJ,Tucker SM,Ingelsson M,Hyman B,et al.The Alzheimer’s disease-associated amyloid β-protein is an antimicrobial peptide.PLoS One.2010;5:e9505.

[339] Kumar DKV,Choi SH,Washicosky KJ,Eimer WA,Tucker S,Ghofrani J,et al.Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease.Sci Transl Med.2016;8:340ra72.

[340] Protto V,Marcocci ME,Miteva MT,Piacentini R,Li Puma DD,Grassi C,et al.Role of HSV-1 in Alzheimer’s disease pathogenesis: A challenge for novel preventive/therapeutic strategies.Curr Opin Pharmacol.2022;63:102200.

[341] Itzhaki RF.Overwhelming Evidence for a Major Role for Herpes Simplex Virus Type 1 (HSV1) in Alzheimer’s Disease (AD); Underwhelming Evidence against.Vaccines (Basel).2021;9:679.

[342] Harris SA,Harris EA.Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer’s Disease.J Alzheimers Dis.2015;48:319-53.

[343] Eimer WA,Vijaya Kumar DK,Navalpur Shanmugam NK,Rodriguez AS,Mitchell T,Washicosky KJ,et al.Alzheimer’s Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection.Neuron.2018;99:56-63.e3.

[344] Tzeng NS,Chung CH,Lin FH,Chiang CP,Yeh CB,Huang SY,et al.Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections—a Nationwide, Population-Based Cohort Study in Taiwan.Neurotherapeutics.2018;15:417-29.

[345] Sneideris T,Erkamp NA,Ausserwöger H,Saar KL,Welsh TJ,Qian D,et al.Targeting nucleic acid phase transitions as a mechanism of action for antimicrobial peptides.Nat Commun.2023;14:7170.

[346] Huan Y,Kong Q,Mou H,Yi H.Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields.Front Microbiol.2020;11:582779.

[347] Perdikari TM,Murthy AC,Ryan VH,Watters S,Naik MT,Fawzi NL.SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs.EMBO J.2020;39:e106478.

[348] Chau BA,Chen V,Cochrane AW,Parent LJ,Mouland AJ.Liquid-liquid phase separation of nucleocapsid proteins during SARS-CoV-2 and HIV-1 replication.Cell Rep.2023;42:111968.

[349] Cubuk J,Alston JJ,Incicco JJ,Singh S,Stuchell-Brereton MD,Ward MD,et al.The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA.Nat Commun.2021;12:1936.

[350] Carlson CR,Asfaha JB,Ghent CM,Howard CJ,Hartooni N,Safari M,et al.Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein Suggests a Biophysical Basis for its Dual Functions.Mol Cell.2020;80:1092-103.e4.

[351] Iserman C,Roden CA,Boerneke MA,Sealfon RSG,McLaughlin GA,Jungreis I,et al.Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid.Mol Cell.2020;80:1078-91.e6.

[352] Chen H,Cui Y,Han X,Hu W,Sun M,Zhang Y,et al.Liquid–liquid phase separation by SARS-CoV-2 nucleocapsid protein and RNA.Cell Res.2020;30:1143-5.

[353] Jha PK,Desai PS,Li J,Larson RG.pH and Salt Effects on the Associative Phase Separation of Oppositely Charged Polyelectrolytes.Polymers.2014;6:1414-36.

[354] Portz B,Lee BL,Shorter J.FUS and TDP-43 Phases in Health and Disease.Trends Biochem Sci.2021;46:550-63.

[355] Campanile M,Kurtul ED,Dec R,Möbitz S,Del Vecchio P,Petraccone L,et al.Morphological Transformations of SARS-CoV-2 Nucleocapsid Protein Biocondensates Mediated by Antimicrobial Peptides.Chemistry.2024;30:e202400048.

[356] Motyl JA,Gromadzka G,Czapski GA,Adamczyk A.SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms.Int J Mol Sci.2024;25:12079.

[357] Dang M,Song J.CTD of SARS-CoV-2 N protein is a cryptic domain for binding ATP and nucleic acid that interplay in modulating phase separation.Protein Sci.2022;31:345-56.

[358] Dang M,Li T,Song J.ATP and nucleic acids competitively modulate LLPS of the SARS-CoV2 nucleocapsid protein.Commun Biol.2023;6:80.

[359] López-Ayllón BD,Marin S,Fernández MF,García-García T,Fernández-Rodríguez R,de Lucas-Rius A,et al.Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10.J Med Virol.2024;96:e29752.

[360] Guarnieri JW,Dybas JM,Fazelinia H,Kim MS,Frere J,Zhang Y,et al.Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts.Sci Transl Med.2023;15:eabq1533.

[361] Homma ST,Wang X,Frere JJ,Gower AC,Zhou J,Lim JK,et al.Respiratory SARS-CoV-2 Infection Causes Skeletal Muscle Atrophy and Long-Lasting Energy Metabolism Suppression.Biomedicines.2024;12:1443.

[362] Garbsch R,Schäfer H,Mooren FC,Schmitz B.Analysis of fat oxidation capacity during cardiopulmonary exercise testing indicates long-lasting metabolic disturbance in patients with post-covid-19 syndrome.Clin Nutr.2024;43:26-35.

[363] Nardacci R,Colavita F,Castilletti C,Lapa D,Matusali G,Meschi S,et al.Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis.Cell Death Dis.2021;12:263.

[364] Xu WT,An XB,Chen MJ,Ma J,Wang XQ,Yang JN,et al.A Gene Cluster of Mitochondrial Complexes Contributes to the Cognitive Decline of COVID-19 Infection.Mol Neurobiol.2024;[Epub ahead of print]

[365] Jourdain AA,Begg BE,Mick E,Shah H,Calvo SE,Skinner OS,et al.Loss of LUC7L2 and U1 snRNP subunits shifts energy metabolism from glycolysis to OXPHOS.Mol Cell.2021;81:1905-19.e12.

[366] Hanson BA,Visvabharathy L,Orban ZS,Jimenez M,Batra A,Liotta EM,et al.Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection.Brain Behav Immun.2023;114:462-74.

[367] Yan X,Chen X,Hou S,Li X,Ju J,Shan Z,et al.A Novel Cyanine-Based Fluorescent Dye for Targeted Mitochondrial Imaging in Neurotoxic Conditions and In Vivo Brain StudiesbioRxiv 2024.10.24.619902 [Preprint]. 2024 [cited 2024 Dec 4]. Available from: https://doi.org/10.1101/2024.10.24.619902

[368] Guarnieri JW,Haltom JA,Albrecht YES,Lie T,Olali AZ,Widjaja GA,et al.SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19.Pharmacol Res.2024;204:107170.

[369] Bojkova D,Costa R,Reus P,Bechtel M,Jaboreck MC,Olmer R,et al.Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy.Metabolites.2021;11:699.

[370] Polcicova K,Badurova L,Tomaskova J.Metabolic reprogramming as a feast for virus replication.Acta Virol.2020;64:201-15.

[371] Haller CJ,Acker J,Arguello AE,Borodavka A.Phase separation and viral factories: unveiling the physical processes supporting RNA packaging in dsRNA viruses.Biochem Soc Trans.2024;52:2101-12.

[372] Calzari L,Dragani DF,Zanotti L,Inglese E,Danesi R,Cavagnola R,et al.Epigenetic patterns, accelerated biological aging, and enhanced epigenetic drift detected 6 months following COVID-19 infection: insights from a genome-wide DNA methylation study.Clin Epigenetics.2024;16:112.

[373] Liu Y,Feng W,Wang Y,Wu B.Crosstalk between protein post-translational modifications and phase separation.Cell Commun Signal.2024;22:110.

[374] Elfawy HA,Das B.Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies.Life Sci.2019;218:165-84.

[375] Grimm A,Eckert A.Brain aging and neurodegeneration: from a mitochondrial point of view.J Neurochem.2017;143:418-31.

[376] Lin MT,Beal MF.Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.Nature.2006;443:787-95.

[377] Zhang T,Li Y,Pan L,Sha J,Bailey M,Faure-Kumar E,et al.Brain-wide alterations revealed by spatial transcriptomics and proteomics in COVID-19 infection.Nat Aging.2024;4:1598-618.

[378] Silverstein A,Wan J,Yen K,Mehta H,Kumagai H,Flores M,et al.Mitochondrial Gene Signatures Illuminate Mitochondrial Function as an Important Contributor to Post-COVID Recovery and Long COVID ProgressionHeliyon [Preprint]. 2024 [cited 2024 Dec 4]. Available from: https://dx.doi.org/10.2139/ssrn.4950019

[379] Chausse B,Malorny N,Lewen A,Poschet G,Berndt N,Kann O.Metabolic flexibility ensures proper neuronal network function in moderate neuroinflammation.Sci Rep.2024;14:14405.

[380] Pfeiffer T,Schuster S,Bonhoeffer S.Cooperation and competition in the evolution of ATP-producing pathways.Science.2001;292:504-7.

[381] Iwata R,Vanderhaeghen P.Regulatory roles of mitochondria and metabolism in neurogenesis.Curr Opin Neurobiol.2021;69:231-40.

[382] Kokotos AC,Antoniazzi AM,Unda SR,Ko MS,Park D,Eliezer D,et al.Phosphoglycerate kinase is a central leverage point in Parkinson’s disease-driven neuronal metabolic deficits.Sci Adv.2024;10:eadn6016.

[383] Tan DX,Manchester LC,Liu X,Rosales-Corral SA,Acuna-Castroviejo D,Reiter RJ.Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin’s primary function and evolution in eukaryotes.J Pineal Res.2013;54:127-38.

[384] Tan DX,Reiter RJ.Mitochondria: the birth place, battle ground and the site of melatonin metabolism in cells.Melatonin Res.2019;2:44-66.

[385] Suofu Y,Li W,Jean-Alphonse FG,Jia J,Khattar NK,Li J,et al.Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release.Proc Natl Acad Sci U S A.2017;114:E7997-8006.

[386] Reiter RJ,Ma Q,Sharma R.Melatonin in Mitochondria: Mitigating Clear and Present Dangers.Physiology (Bethesda).2020;35:86-95.

[387] Williams JF,Blackmore PF,Clark MG.New reaction sequences for the non-oxidative pentose phosphate pathway.Biochem J.1978;176:257-82.

[388] Sertbas M,Ulgen KO.Uncovering the Effect of SARS-CoV-2 on Liver Metabolism via Genome-Scale Metabolic Modeling for Reprogramming and Therapeutic Strategies.ACS Omega.2024;9:15535-46.

[389] Whiley L,Lawler NG,Zeng AX,Lee A,Chin ST,Bizkarguenaga M,et al.Cross-Validation of Metabolic Phenotypes in SARS-CoV-2 Infected Subpopulations Using Targeted Liquid Chromatography-Mass Spectrometry (LC-MS).J Proteome Res.2024;23:1313-27.

[390] Ryu KW,Fung TS,Baker DC,Saoi M,Park J,Febres-Aldana CA,et al.Cellular ATP demand creates metabolically distinct subpopulations of mitochondria.Nature.2024;635:746-54.

[391] Zhu J,Schwörer S,Berisa M,Kyung YJ,Ryu KW,Yi J,et al.Mitochondrial NADP(H) generation is essential for proline biosynthesis.Science.2021;372:968-72.

[392] Monné M,Miniero DV,Daddabbo L,Palmieri L,Porcelli V,Palmieri F.Mitochondrial transporters for ornithine and related amino acids: a review.Amino Acids.2015;47:1763-77.

[393] Farook MR,Croxford Z,Morgan S,Horlock AD,Holt AK,Rees A,et al.Loss of mitochondrial pyruvate carrier 1 supports proline-dependent proliferation and collagen biosynthesis in ovarian cancer.Mol Metab.2024;81:101900.

[394] Fry MY,Navarro PP,Hakim P,Ananda VY,Qin X,Landoni JC,et al.In situ architecture of Opa1-dependent mitochondrial cristae remodeling.EMBO J.2024;43:391-413.

[395] Spikes TE,Montgomery MG,Walker JE.Interface mobility between monomers in dimeric bovine ATP synthase participates in the ultrastructure of inner mitochondrial membranes.Proc Natl Acad Sci U S A.2021;118:e2021012118.

[396] Afzal N,Lederer WJ,Jafri MS,Mannella CA.Effect of crista morphology on mitochondrial ATP output: A computational study.Curr Res Physiol.2021;4:163-76.

[397] Shin HJ,Lee W,Ku KB,Yoon GY,Moon HW,Kim C,et al.SARS-CoV-2 aberrantly elevates mitochondrial bioenergetics to induce robust virus propagation.Signal Transduct Target Ther.2024;9:125.

[398] Reiter RJ,Sharma RN,Manucha W,Rosales-Corral S,Almieda Chuffa LG,Loh D,et al.Dysfunctional mitochondria in age-related neurodegeneration: Utility of melatonin as an antioxidant treatment.Ageing Res Rev.2024;101:102480.

[399] Cucielo MS,Cesário RC,Silveira HS,Gaiotte LB,Dos Santos SAA,de Campos Zuccari DAP,et al.Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation.Molecules.2022;27:4350.

[400] Reiter RJ,Sharma R,Ma Q,Rosales-Corral S,Acuna-Castroviejo D,Escames G.Inhibition of mitochondrial pyruvate dehydrogenase kinase: a proposed mechanism by which melatonin causes cancer cells to overcome cytosolic glycolysis, reduce tumor biomass and reverse insensitivity to chemotherapy.Melatonin Res.2019;2:105-19.

[401] Rahmani S,Roohbakhsh A,Pourbarkhordar V,Hayes AW,Karimi G.Melatonin regulates mitochondrial dynamics and mitophagy: Cardiovascular protection.J Cell Mol Med.2024;28:e70074.

[402] Tan DX,Manchester LC,Qin L,Reiter RJ.Melatonin: A Mitochondrial Targeting Molecule Involving Mitochondrial Protection and Dynamics.Int J Mol Sci.2016;17:2124.

[403] Zhang Y,Wang Y,Xu J,Tian F,Hu S,Chen Y,et al.Melatonin attenuates myocardial ischemia-reperfusion injury via improving mitochondrial fusion/mitophagy and activating the AMPK-OPA1 signaling pathways.J Pineal Res.2019;66:e12542.

[404] Chen WR,Zhou YJ,Yang JQ,Liu F,Wu XP,Sha Y.Melatonin Attenuates Calcium Deposition from Vascular Smooth Muscle Cells by Activating Mitochondrial Fusion and Mitophagy via an AMPK/OPA1 Signaling Pathway.Oxid Med Cell Longev.2020;2020:5298483.

[405] Salagre D,Raya Álvarez E,Cendan CM,Aouichat S,Agil A.Melatonin Improves Skeletal Muscle Structure and Oxidative Phenotype by Regulating Mitochondrial Dynamics and Autophagy in Zücker Diabetic Fatty Rat.Antioxidants (Basel).2023;12:1499.

[406] Chang JY,Yu F,Shi L,Ko ML,Ko GY.Melatonin Affects Mitochondrial Fission/Fusion Dynamics in the Diabetic Retina.J Diabetes Res.2019;2019:8463125.

[407] Ding M,Ning J,Feng N,Li Z,Liu Z,Wang Y,et al.Dynamin-related protein 1-mediated mitochondrial fission contributes to post-traumatic cardiac dysfunction in rats and the protective effect of melatonin.J Pineal Res.2018;64:e12447.

[408] Ge X,Wang C,Yang G,Maimaiti D,Hou M,Liu H,et al.Enhancement of mitochondrial energy metabolism by melatonin promotes vascularized skeletal muscle regeneration in a volumetric muscle loss model.Free Radic Biol Med.2024;210:146-57.

[409] Lv N,Hou M,Deng L,Hua X,Zhou X,Liu H,et al.A sponge-like nanofiber melatonin-loaded scaffold accelerates vascularized bone regeneration via improving mitochondrial energy metabolism.Mater Today Bio.2024;26:101078.

[410] Agil A,Navarro-Alarcon M,Ali FAZ,Albrakati A,Salagre D,Campoy C,et al.Melatonin Enhances the Mitochondrial Functionality of Brown Adipose Tissue in Obese—Diabetic Rats.Antioxidants (Basel).2021;10:1482.

[411] Rodríguez MI,Escames G,López LC,López A,García JA,Ortiz F,et al.Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice.Exp Gerontol.2008;43:749-56.

[412] López LC,Escames G,Ortiz F,Ros E,Acuña-Castroviejo D.Melatonin restores the mitochondrial production of ATP in septic mice.Neuro Endocrinol Lett.2006;27:623-30.

[413] Vairetti M,Ferrigno A,Bertone R,Rizzo V,Richelmi P,Bertè F,et al.Exogenous melatonin enhances bile flow and ATP levels after cold storage and reperfusion in rat liver: implications for liver transplantation.J Pineal Res.2005;38:223-30.

[414] Freitas I,Bertone V,Guarnaschelli C,Ferrigno A,Boncompagni E,Rizzo V,et al.In situ demonstration of improvement of liver mitochondria function by melatonin after cold ischemia.In Vivo.2006;20:229-37.

[415] López A,García JA,Escames G,Venegas C,Ortiz F,López LC,et al.Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production.J Pineal Res.2009;46:188-98.

[416] Martín M,Macías M,Escames G,Reiter RJ,Agapito MT,Ortiz GG,et al.Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo.J Pineal Res.2000;28:242-8.

[417] Bonomi RE,Riordan W,Gelovani JG.The Structures, Functions, and Roles of Class III HDACs (Sirtuins) in Neuropsychiatric Diseases.Cells.2024;13:1644.

[418] Garcia Morato J,Hans F,von Zweydorf F,Feederle R,Elsässer SJ,Skodras AA,et al.Sirtuin-1 sensitive lysine-136 acetylation drives phase separation and pathological aggregation of TDP-43.Nat Commun.2022;13:1223.

[419] Qin Z,Fang X,Sun W,Ma Z,Dai T,Wang S,et al.Deactylation by SIRT1 enables liquid-liquid phase separation of IRF3/IRF7 in innate antiviral immunity.Nat Immunol.2022;23:1193-207.

[420] Ahn BH,Kim HS,Song S,Lee IH,Liu J,Vassilopoulos A,et al.A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis.Proc Natl Acad Sci U S A.2008;105:14447-52.

[421] Yu L,Gong B,Duan W,Fan C,Zhang J,Li Z,et al.Melatonin ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic rats by preserving mitochondrial function: role of AMPK-PGC-1α-SIRT3 signaling.Sci Rep.2017;7:41337.

[422] Qu J,Hu H,Niu H,Sun X,Li Y.Melatonin restores the declining maturation quality and early embryonic development of oocytes in aged mice.Theriogenology.2023;210:110-8.

[423] Niu YJ,Zhou W,Nie ZW,Shin KT,Cui XS.Melatonin enhances mitochondrial biogenesis and protects against rotenone-induced mitochondrial deficiency in early porcine embryos.J Pineal Res.2020;68:e12627.

[424] Jiang P,Du W,Wu M.Regulation of the pentose phosphate pathway in cancer.Protein Cell.2014;5:592-602.

[425] Chen X,Hao B,Li D,Reiter RJ,Bai Y,Abay B,et al.Melatonin inhibits lung cancer development by reversing the Warburg effect via stimulating the SIRT3/PDH axis.J Pineal Res.2021;71:e12755.